155 related articles for article (PubMed ID: 12697169)
21. Norcantharidin analogues: a patent review (2006 - 2010).
Deng L; Tang S
Expert Opin Ther Pat; 2011 Nov; 21(11):1743-53. PubMed ID: 22017412
[TBL] [Abstract][Full Text] [Related]
22. Radiosensitization of tumour cells by cantharidin and some analogues.
Price WA; Stobbe CC; Park SJ; Chapman JD
Int J Radiat Biol; 2004 Apr; 80(4):269-79. PubMed ID: 15204704
[TBL] [Abstract][Full Text] [Related]
23. In vitro anti-proliferation/cytotoxic activity of cantharidin (Spanish Fly) and related derivatives.
Williams LA; Möller W; Merisor E; Kraus W; Rösner H
West Indian Med J; 2003 Mar; 52(1):10-3. PubMed ID: 12806747
[TBL] [Abstract][Full Text] [Related]
24. Cytotoxicity of cantharidin analogues targeting protein phosphatase 2A.
Shan HB; Cai YC; Liu Y; Zeng WN; Chen HX; Fan BT; Liu XH; Xu ZL; Wang B; Xian LJ
Anticancer Drugs; 2006 Sep; 17(8):905-11. PubMed ID: 16940800
[TBL] [Abstract][Full Text] [Related]
25. Optically active cantharidin analogues possessing selective inhibitory activity on Ser/Thr protein phosphatase 2B (calcineurin): implications for the binding mode.
Baba Y; Hirukawa N; Sodeoka M
Bioorg Med Chem; 2005 Sep; 13(17):5164-70. PubMed ID: 15951185
[TBL] [Abstract][Full Text] [Related]
26. Retro-Diels-Alder reaction: possible involvement in the metabolic activation of 7-oxabicyclo[2.2.1]hepta-2(3),5(6)-diene-2,3-dicarboxylates and a phosphonate analog.
Mahajna M; Quistad GB; Casida JE
Chem Res Toxicol; 1996; 9(1):241-6. PubMed ID: 8924598
[TBL] [Abstract][Full Text] [Related]
27. Exploiting protein phosphatase inhibitors based on cantharidin analogues for cancer drug discovery.
Deng L; Dong J; Wang W
Mini Rev Med Chem; 2013 Jun; 13(8):1166-76. PubMed ID: 23373656
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of Canthardin Sulfanilamides and Their Acid Anhydride Analogues via a Ring-Opening Reaction of Activated Aziridines and Their Associated Pharmacological Effects.
Chiang LL; Tseng IJ; Lin PY; Sheu SY; Lin CT; Hsieh YH; Lin YJ; Chen HL; Lin MH
Molecules; 2016 Jan; 21(1):100. PubMed ID: 26784163
[TBL] [Abstract][Full Text] [Related]
29. Protein phosphatase 1 and 2A inhibitors activate acyl-CoA:cholesterol acyltransferase and cholesterol ester formation in isolated rat hepatocytes.
Hernández ML; Martínez MJ; López de Heredia M; Ochoa B
Biochim Biophys Acta; 1997 Nov; 1349(3):233-41. PubMed ID: 9434137
[TBL] [Abstract][Full Text] [Related]
30. Norcantharimide analogues possessing terminal phosphate esters and their anti-cancer activity.
Robertson MJ; Gordon CP; Gilbert J; McCluskey A; Sakoff JA
Bioorg Med Chem; 2011 Sep; 19(18):5734-41. PubMed ID: 21855357
[TBL] [Abstract][Full Text] [Related]
31. Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A.
Honkanen RE
FEBS Lett; 1993 Sep; 330(3):283-6. PubMed ID: 8397101
[TBL] [Abstract][Full Text] [Related]
32. Endothall thioanhydride inhibits protein phosphatases-1 and -2A in vivo.
Erdödi F; Tóth B; Hirano K; Hirano M; Hartshorne DJ; Gergely P
Am J Physiol; 1995 Nov; 269(5 Pt 1):C1176-84. PubMed ID: 7491907
[TBL] [Abstract][Full Text] [Related]
33. Cantharidin analogue alleviates dextran sulfate sodium-induced colitis in mice by inhibiting the activation of NF-κB signaling.
Wu Y; Liu Z; He Z; Yi J; Qiao X; Tan C; Xing Y; Zeng Y; Yang D; Yin J; Fan B; Zeng G
Eur J Med Chem; 2023 Nov; 260():115731. PubMed ID: 37643546
[TBL] [Abstract][Full Text] [Related]
34. Methotrexate analogues. 34. Replacement of the glutamate moiety in methotrexate and aminopterin by long-chain 2-aminoalkanedioic acids.
Rosowsky A; Bader H; Kohler W; Freisheim JH; Moran RG
J Med Chem; 1988 Jul; 31(7):1338-44. PubMed ID: 2898531
[TBL] [Abstract][Full Text] [Related]
35. A simple procedure for preparation of N-thiazol, thiadiazol, pyridyl and sulfanylamidocantharidinimines analogues and evaluation of their cytotoxicities against human HL-60, MCF7, Neuro-2a and A549 carcinoma cell.
Tseng IJ; Sheu SY; Chen YT; Huang CY; Lin CT; Lin PY
Chem Pharm Bull (Tokyo); 2012; 60(11):1453-7. PubMed ID: 23124569
[TBL] [Abstract][Full Text] [Related]
36. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
37. Cantharidin-based small molecules as potential therapeutic agents.
Puerto Galvis CE; Vargas Méndez LY; Kouznetsov VV
Chem Biol Drug Des; 2013 Nov; 82(5):477-99. PubMed ID: 23809227
[TBL] [Abstract][Full Text] [Related]
38. Apoptotic activity of a novel synthetic cantharidin analogue on hepatoma cell lines.
Kok SH; Chui CH; Lam WS; Chen J; Lau FY; Cheng GY; Wong RS; Lai PP; Leung TW; Tang JC; Chan AS
Int J Mol Med; 2006 May; 17(5):945-9. PubMed ID: 16596285
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and structure-activity relationship studies of cytotoxic epoxide derivatives of 7-oxabicyclo[2.2.1]heptane.
Anderson WK; Dewey RH
J Med Chem; 1977 Feb; 20(2):306-8. PubMed ID: 836504
[TBL] [Abstract][Full Text] [Related]
40. Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin.
Bertini I; Calderone V; Fragai M; Luchinat C; Talluri E
J Med Chem; 2009 Aug; 52(15):4838-43. PubMed ID: 19601647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
